Anhui Anke BioTech Group
300009.SHE
| Exchange: | SHE |
| Currency | Renminbi |
| ISIN: | CNE100000GY2 |
| Primary Ticker: | 300009.SHE |
| Fiscal Year End: | December |
| IPO Date: | 2009-10-30 |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide AP Is; beauty care products, including anti-aging, masks, and essential liquids; mouthwash; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits; paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. Additionally, the company offers monoclonal antibody drugs, such as Trastuzumab to treat patients with breast and gastric cancers under the ANTRASTUIN brand; Bevacizumab for the treatment of non-small cell lung cancer; and anti-PD1 for advanced cancers. The company was founded in 2000 and is based in Hefei, China. |
| Address: | K-1, Anke Bio Building, Hefei, China, 230088 |
| Website: | https://www.ankebio.com |
| Full Time Employees: | 2986 |
| Updated On: | 2024-11-02 |
Highlights
| Market Capitalization: | 15187731456 |
| Market Capitalization Mln: | 15187.73 |
| EBITDA: | 921047232 |
| PE Ratio: | 19.27 |
| Wall Street Target Price: | 19.54 |
| Book Value: | 2.28 |
| Dividend Share: | 0.25 |
| Dividend Yield: | 0.02 |
| Earnings Share: | 0.47 |
| EPS Estimate Current Year: | 0.62 |
| EPS Estimate Next Year: | 0.77 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.28 |
| Operating Margin TTM: | 0.32 |
| Return On Assets TTM: | 0.10 |
| Return On Equity TTM: | 0.20 |
| Revenue TTM: | 2765648128 |
| Revenue Per Share TTM: | 1.66 |
| Quarterly Revenue Growth YOY: | -0.15 |
| Gross Profit TTM: | 1827687736 |
| Diluted Eps TTM: | 0.47 |
| Quarterly Earnings Growth YOY: | -0.32 |
Valuation
| Trailing PE: | 19.27 |
| Price Sales TTM: | 5.49 |
| Price Book MRQ: | 3.85 |
| Enterprise Value: | 13973620277 |
| Enterprise Value Revenue: | 5.05 |
| Enterprise Value Ebitda: | 16.37 |
Shares
| Shares Outstanding: | 1676349952 |
| Shares Float: | 1061518143 |
| Percent Insiders: | 38.52 |
| Percent Institutions: | 7.57 |
Technicals
| Beta: | 0.56 |
| 52 Week High: | 11.55 |
| 52 Week Low: | 7.36 |
| 50 Day MA: | 8.53 |
| 200 Day MA: | 9.14 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.25 |
| Forward Annual Dividend Yield: | 0.02 |
| Payout Ratio: | 0.52 |
| Ex Dividend Date: | 2024-05-27 |
| Last Split Factor: | 1.2:1 |
| Last Split Date: | 2021-05-14 |
Earnings
| Report Date: | 2025-04-18 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | CNY |
| Report Date: | 2024-10-24 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.10 |
| Report Date: | 2024-08-28 |
| Date: | 2024-06-30 |
| Currency: | CNY |
| Eps Actual: | 0.12 |
| Report Date: | 2024-04-25 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.13 |
| Report Date: | 2024-03-27 |
| Date: | 2023-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.11 |
| Report Date: | 2023-10-24 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.15 |
| Report Date: | 2023-08-23 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.12 |
| Report Date: | 2023-04-27 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.11 |
| Report Date: | 2023-03-27 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.07 |
| Report Date: | 2022-10-25 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.15 |
| Report Date: | 2022-08-24 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.11 |
| Report Date: | 2022-04-27 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.11 |
| Report Date: | 2022-03-30 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | -0.14 |
| Report Date: | 2021-10-28 |
| Date: | 2021-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.11 |
| Report Date: | 2021-08-19 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.07 |
| Report Date: | 2021-04-07 |
| Date: | 2021-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2020-10-28 |
| Date: | 2020-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.08 |
| Report Date: | 2020-08-25 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.05 |
| Report Date: | 2020-04-28 |
| Date: | 2020-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.05 |
| Report Date: | 2020-02-28 |
| Date: | 2019-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | -0.08 |
| Report Date: | 2019-10-24 |
| Date: | 2019-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.06 |
| Report Date: | 2019-08-27 |
| Date: | 2019-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2019-04-24 |
| Date: | 2019-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2019-02-27 |
| Date: | 2018-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2018-10-29 |
| Date: | 2018-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.08 |
| Report Date: | 2018-08-23 |
| Date: | 2018-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.06 |
| Report Date: | 2018-04-25 |
| Date: | 2018-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.06 |
| Report Date: | 2018-02-27 |
| Date: | 2017-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.05 |
| Report Date: | 2017-10-25 |
| Date: | 2017-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2017-08-22 |
| Date: | 2017-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2017-04-26 |
| Date: | 2017-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2017-03-01 |
| Date: | 2016-12-31 |
| Before After Market: | Before Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2016-10-25 |
| Date: | 2016-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2016-08-23 |
| Date: | 2016-06-30 |
| Before After Market: | Before Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2016-04-26 |
| Date: | 2016-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.01 |
| Report Date: | 2016-02-26 |
| Date: | 2015-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.01 |
| Report Date: | 2015-10-25 |
| Date: | 2015-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.03 |
| Report Date: | 2015-08-11 |
| Date: | 2015-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.02 |
| Report Date: | 2015-04-22 |
| Date: | 2015-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.01 |
| Report Date: | 2015-02-17 |
| Date: | 2014-12-31 |
| Before After Market: | Before Market |
| Currency: | CNY |
| Eps Actual: | 0.01 |
| Report Date: | 2014-10-21 |
| Date: | 2014-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.02 |
| Report Date: | 2014-08-19 |
| Date: | 2014-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.01 |
| Date: | 2025-12-31 |
| Period: | +1y |
| Growth: | 0.24 |
| Earnings Estimate Avg: | 0.77 |
| Earnings Estimate Low: | 0.73 |
| Earnings Estimate High: | 0.81 |
| Earnings Estimate Year Ago Eps: | 0.62 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 0.24 |
| Revenue Estimate Avg: | 4380500000.00 |
| Revenue Estimate Low: | 4339000000.00 |
| Revenue Estimate High: | 4422000000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.22 |
| Eps Trend Current: | 0.77 |
| Eps Trend7days Ago: | 0.77 |
| Eps Trend30days Ago: | 0.77 |
| Eps Trend60days Ago: | 0.77 |
| Eps Trend90days Ago: | 0.78 |
| Date: | 2024-12-31 |
| Growth: | 0.21 |
| Earnings Estimate Avg: | 0.62 |
| Earnings Estimate Low: | 0.61 |
| Earnings Estimate High: | 0.64 |
| Earnings Estimate Year Ago Eps: | 0.51 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 0.21 |
| Revenue Estimate Avg: | 3587500000.00 |
| Revenue Estimate Low: | 3565000000.00 |
| Revenue Estimate High: | 3610000000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.25 |
| Eps Trend Current: | 0.62 |
| Eps Trend7days Ago: | 0.62 |
| Eps Trend30days Ago: | 0.62 |
| Eps Trend60days Ago: | 0.62 |
| Eps Trend90days Ago: | 0.63 |
| Date: | 2024-03-31 |
| Period: | +1q |
| Date: | 2023-12-31 |
| Growth: | 0.18 |
| Earnings Estimate Avg: | 0.51 |
| Earnings Estimate Low: | 0.47 |
| Earnings Estimate High: | 0.55 |
| Earnings Estimate Year Ago Eps: | 0.43 |
| Earnings Estimate Number Of Analysts: | 6.00 |
| Earnings Estimate Growth: | 0.18 |
| Revenue Estimate Avg: | 2892020000.00 |
| Revenue Estimate Low: | 2779000000.00 |
| Revenue Estimate High: | 3009000000.00 |
| Revenue Estimate Number Of Analysts: | 6.00 |
| Revenue Estimate Growth: | 0.24 |
| Eps Trend Current: | 0.51 |
| Eps Trend7days Ago: | 0.51 |
| Eps Trend30days Ago: | 0.52 |
| Eps Trend60days Ago: | 0.52 |
| Eps Trend90days Ago: | 0.52 |
| Date: | 2023-03-31 |
| Period: | +1q |
| Date: | 2022-12-31 |
| Growth: | 2.30 |
| Earnings Estimate Avg: | 0.43 |
| Earnings Estimate Low: | 0.41 |
| Earnings Estimate High: | 0.45 |
| Earnings Estimate Year Ago Eps: | 0.13 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 2.30 |
| Revenue Estimate Avg: | 2800500000.00 |
| Revenue Estimate Low: | 2782000000.00 |
| Revenue Estimate High: | 2819000000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.29 |
| Eps Trend Current: | 0.43 |
| Eps Trend7days Ago: | 0.43 |
| Eps Trend30days Ago: | 0.41 |
| Eps Trend60days Ago: | 0.41 |
| Eps Trend90days Ago: | 0.40 |
| Date: | 2022-09-30 |
| Period: | +1q |
| Date: | 2022-06-30 |
| Revenue Estimate Avg: | 625957000.00 |
| Revenue Estimate Growth: | 0.29 |
| Date: | 2022-03-31 |
| Period: | +1q |
| Revenue Estimate Avg: | 533355000.00 |
| Revenue Estimate Growth: | 0.10 |
| Date: | 2021-12-31 |
| Revenue Estimate Avg: | 2680640000.00 |
| Revenue Estimate Low: | 2614000000.00 |
| Revenue Estimate High: | 2782000000.00 |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Revenue Estimate Growth: | 0.23 |
| Date: | 2019-12-31 |
| Period: | +1y |
| Growth: | 0.31 |
| Earnings Estimate Year Ago Eps: | 0.38 |
| Earnings Estimate Growth: | 0.31 |
| Revenue Estimate Avg: | 1886610000.00 |
| Revenue Estimate Low: | 1731150000.00 |
| Revenue Estimate High: | 2044000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.27 |
| Eps Trend7days Ago: | 0.49 |
| Eps Trend30days Ago: | 0.49 |
| Eps Trend60days Ago: | 0.49 |
| Eps Trend90days Ago: | 0.49 |
| Date: | 2019-06-30 |
| Period: | +1q |
| Revenue Estimate Avg: | 1483860000.00 |
| Revenue Estimate Low: | 1392440000.00 |
| Revenue Estimate High: | 1592000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.35 |
| Date: | 2019-03-31 |
| Revenue Estimate Avg: | 1483860000.00 |
| Revenue Estimate Low: | 1392440000.00 |
| Revenue Estimate High: | 1592000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.35 |
| Date: | 2018-12-31 |
| Growth: | 0.35 |
| Earnings Estimate Year Ago Eps: | 0.28 |
| Earnings Estimate Growth: | 0.35 |
| Revenue Estimate Avg: | 1483860000.00 |
| Revenue Estimate Low: | 1392440000.00 |
| Revenue Estimate High: | 1592000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.35 |
| Eps Trend7days Ago: | 0.36 |
| Eps Trend30days Ago: | 0.36 |
| Eps Trend60days Ago: | 0.36 |
| Eps Trend90days Ago: | 0.36 |
| Date: | 2018-09-30 |
| Period: | +1q |
| Date: | 2018-06-30 |
| Date: | 2018-03-31 |
| Date: | 2017-12-31 |
| Growth: | 0.42 |
| Earnings Estimate Avg: | 0.40 |
| Earnings Estimate Low: | 0.38 |
| Earnings Estimate High: | 0.42 |
| Earnings Estimate Year Ago Eps: | 0.28 |
| Earnings Estimate Number Of Analysts: | 7.00 |
| Earnings Estimate Growth: | 0.42 |
| Revenue Estimate Avg: | 1083220000.00 |
| Revenue Estimate Low: | 1043000000.00 |
| Revenue Estimate High: | 1121000000.00 |
| Revenue Estimate Number Of Analysts: | 7.00 |
| Revenue Estimate Growth: | 0.27 |
| Eps Trend Current: | 0.40 |
| Eps Trend7days Ago: | 0.40 |
| Eps Trend30days Ago: | 0.40 |
| Eps Trend60days Ago: | 0.40 |
| Eps Trend90days Ago: | 0.40 |
| Date: | 2024-09-30 |
| Eps Actual: | 0.36 |
| Date: | 2023-12-31 |
| Eps Actual: | 0.51 |
| Date: | 2022-12-31 |
| Eps Actual: | 0.4 |
| Date: | 2021-12-31 |
| Eps Actual: | 0.26 |
| Date: | 2019-12-31 |
| Eps Actual: | 0.07 |
| Date: | 2018-12-31 |
| Eps Actual: | 0.2 |
| Date: | 2017-12-31 |
| Eps Actual: | 0.17 |
| Date: | 2016-12-31 |
| Eps Actual: | 0.12 |
| Date: | 2015-12-31 |
| Eps Actual: | 0.09 |
| Date: | 2014-12-31 |
| Eps Actual: | 0.06 |